Cargando…

Novel PSEN1 (P284S) Mutation Causes Alzheimer's Disease with Cerebellar Amyloid β-Protein Deposition

Background/Objective: AD-associated PSEN1 mutations exhibit high clinical heterogeneity. The discovery of these mutations and the analysis of their associations with cases such as EOAD should be critical to understanding AD's pathogenesis. Methods: We performed clinical analysis, neuroimaging,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Mingrong, Gao, Chenhao, Wang, Huayuan, Shang, Junkui, Liu, Ruijie, You, Yang, Zang, Weizhou, Zhang, Jiewen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933047/ https://www.ncbi.nlm.nih.gov/pubmed/35850649 http://dx.doi.org/10.2174/1567205019666220718151357

Ejemplares similares

Identification and Clinical Analysis of the First Nonsense Mutation in the PSEN1 Gene in a Family With Acute Encephalopathy and Retinitis Pigmentosa
por: You, Chunlin, et al.
Publicado: (2020)

APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease
por: Giau, Vo Van, et al.
Publicado: (2019)

Amyloid-β(1–43) cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
por: Perrone, Federica, et al.
Publicado: (2020)

Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy
por: Li, Xu-Ying, et al.
Publicado: (2021)

The R278I Mutation of PSEN1 in the Familial Alzheimer Disease
por: Kim, Jong Hun, et al.
Publicado: (2020)

Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations
por: Kondo, Takayuki, et al.
Publicado: (2021)

Two Novel Mutations and a de novo Mutation in PSEN1 in Early-onset Alzheimer’s Disease
por: Li, Yu-Sheng, et al.
Publicado: (2019)

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
por: Lanoiselée, Hélène-Marie, et al.
Publicado: (2017)

Both the Complexity of Tight Junctions and Endothelial Transcytosis Are Increased During BBB Postnatal Development in Rats
por: Li, Wei, et al.
Publicado: (2022)

Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
por: Melzer, Tracy R., et al.
Publicado: (2019)

Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer’s Disease
por: Yang, Youngsoon, et al.
Publicado: (2023)

Prominent Striatum Amyloid Retention in Early-Onset Familial Alzheimer's Disease With PSEN1 Mutations: A Pilot PET/MR Study
por: Qin, Qi, et al.
Publicado: (2021)

PSEN1 Compound Heterozygous Mutations Associated with Cerebral Amyloid Angiopathy and Cognitive Decline Phenotype
por: Palmieri, Ilaria, et al.
Publicado: (2021)

APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines
por: Xiao, Xuewen, et al.
Publicado: (2021)

The PSEN1 E280G mutation leads to increased amyloid-β43 production in induced pluripotent stem cell neurons and deposition in brain tissue
por: Willumsen, Nanet, et al.
Publicado: (2022)

Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
por: Withington, Charles G., et al.
Publicado: (2022)

Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012)

Vasculitic Moyamoya syndrome in a patient with paroxysmal nocturnal hemoglobinuria: A case report and literature review
por: Li, Fangfang, et al.
Publicado: (2022)

Identification of PSEN1 and APP Gene Mutations in Korean Patients with Early-Onset Alzheimer's Disease
por: Park, Hyun-Kyung, et al.
Publicado: (2008)

Familial Alzheimer’s Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis
por: Arber, Charles, et al.
Publicado: (2021)

PSEN2 Thr421Met Mutation in a Patient with Early Onset Alzheimer’s Disease
por: Yang, YoungSoon, et al.
Publicado: (2022)

DIRAC (P284)
por: Gravela, B
Publicado: (1995)

Correction: Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012)

The associations of APP , PSEN1 , and PSEN2 genes with Alzheimer's disease: A large case–control study in Chinese population
por: Xiao, Xuewen, et al.
Publicado: (2022)

Amyloid Deposits in the Ligamentum Flavum Related to Lumbar Spinal Canal Stenosis and Lumbar Disc Degeneration
por: Al Yaseen, Mustafa, et al.
Publicado: (2022)

CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation
por: Konstantinidis, Evangelos, et al.
Publicado: (2022)

Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro
por: Raut, Snehal, et al.
Publicado: (2021)

Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer’s disease variants: AβPParc and PSEN1DE9
por: Lemoine, Laetitia, et al.
Publicado: (2020)

Cerebellar cognitive affective syndrome after acute cerebellar stroke
por: Abderrakib, Anissa, et al.
Publicado: (2022)

PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer’s disease-causing Presenilin-1 E280A mutation carriers
por: Ghisays, Valentina, et al.
Publicado: (2021)

An intronic rare mutation in Presenilin-1 (PSEN-1) gene may be involved in the developement of Alzheimer’s disease
por: Bhaumik, Pranami, et al.
Publicado: (2014)

Probable novel PSEN2 Val214Leu mutation in Alzheimer’s disease supported by structural prediction
por: Youn, Young Chul, et al.
Publicado: (2014)

A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer's Disease
por: Vélez, Jorge I., et al.
Publicado: (2016)

PSEN1 L226F mutation in a patient with early-onset Alzheimer’s disease in Korea
por: Bagyinszky, Eva, et al.
Publicado: (2016)

A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer’s disease
por: Van Giau, Vo, et al.
Publicado: (2019)

Early pathogenic event of Alzheimer’s disease documented in iPSCs from patients with PSEN1 mutations
por: Yang, Juan, et al.
Publicado: (2016)

Familial Alzheimer’s disease-associated PSEN1 mutations affect neurodevelopment through increased Notch signaling
por: Hurley, Erin M., et al.
Publicado: (2023)

PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer’s Disease: Data from PUMCH Dementia Cohort
por: Dong, Liling, et al.
Publicado: (2022)

Spastic paraplegia preceding PSEN1‐related familial Alzheimer's disease
por: Chelban, Viorica, et al.
Publicado: (2021)

Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
por: Hsu, Simon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_09r50rii6tsi2tajegmbr0rr0s